Relationships between central corneal thickness and optic disc topography in eyes with glaucoma, suspicion of glaucoma, or ocular hypertension

QR Code

Relationships between central corneal thickness and optic disc topography in eyes with glaucoma, suspicion of glaucoma, or ocular hypertension

Pinakin Gunvant1, Lucia Porsia2, Russell J Watkins3, Henrietta Bayliss-Brown2, David C Broadway21Department of Research, Southern College of Optometry, Memphis, TN, USA; 2Department of Ophthalmology, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK; 3Department of Pathology, Algernon F...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Pinakin Gunvant, Lucia Porsia, Russell J Watkins, Henrietta Bayliss-Brown, David C Broadway
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/b206a50eb30c4a3da941649c9ba475d4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Correlation of central corneal thickness and axial length to the optic disc and peripapillary atrophy among healthy individuals, glaucoma and ocular hypertension patients
par: Michalis Moschos, et autres
Publié: (2008)

Optic disc topography in Malay patients with normal-tension glaucoma and primary open-angle glaucoma
par: Adlina AR, et autres
Publié: (2014)

Topical Medication Therapy for Glaucoma and Ocular Hypertension
par: Tao Wang, et autres
Publié: (2021)

Correlation between ocular perfusion pressure and ocular pulse amplitude in glaucoma, ocular hypertension, and normal eyes
par: Figueiredo BP, et autres
Publié: (2013)

Central corneal thickness and corneal endothelial characteristics in healthy, cataract, and glaucoma patients
par: Galgauskas S, et autres
Publié: (2012)

Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension
par: Pacella F, et autres
Publié: (2012)

Central corneal thickness in black Cameroonian ocular hypertensive and glaucomatous subjects
par: Christelle Domngang Noche, et autres
Publié: (2010)

Diurnal Stability Of Peripapillary Vessel Density And Nerve Fiber Layer Thickness On Optical Coherence Tomography Angiography In Healthy, Ocular Hypertension And Glaucoma Eyes
par: Bochicchio S, et autres
Publié: (2019)

Central corneal thickness in subjects with glaucoma and in normal individuals (with or without pseudoexfoliation syndrome)
par: Georgios Kitsos, et autres
Publié: (2009)

No differences in central corneal thickness between open-angle and pseudoexfoliation glaucoma patients
par: Ayala M, et autres
Publié: (2017)

The influence of axial myopia on optic disc characteristics of glaucoma eyes
par: Jasmin Rezapour, et autres
Publié: (2021)

Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
par: Ji-Hye Park, et autres
Publié: (2021)

Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone
par: M Selim Kocabora, et autres
Publié: (2008)

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
par: Anna Galanopoulos, et autres
Publié: (2008)

Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
par: Lanzl I, et autres
Publié: (2013)

Intraocular pressure 1 year after vitrectomy in eyes without a history of glaucoma or ocular hypertension
par: Fang Y, et autres
Publié: (2017)

Comparative studies of RNFL thickness measured by OCT with global index of visual fields in patients with ocular hypertension and early open angle glaucoma
par: Sergios Taliantzis, et autres
Publié: (2009)

Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
par: Inoue K, et autres
Publié: (2012)

Assessment of corneal hysteresis measured by the ocular response analyzer as a screening tool in patients with glaucoma
par: Schweitzer JA, et autres
Publié: (2018)

Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
par: Ermiş&nbsp;SS
Publié: (2012)

Blood pressure, ocular perfusion pressure and open-angle glaucoma in patients with systemic hypertension
par: Cantor E, et autres
Publié: (2018)

Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma
par: Dimitris Papaconstantinou, et autres
Publié: (2009)

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
par: Gregory Katz, et autres
Publié: (2010)

A review of ocular perfusion pressure and retinal thickness: A case for the role of systemic hypotension in glaucoma
par: Naazia Vawda, et autres
Publié: (2021)

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
par: Dorota Pozarowska
Publié: (2010)

Incidence and Risk Factors of Ocular Hypertension/Glaucoma After Descemet Stripping Automated Endothelial Keratoplasty
par: Elalfy M, et autres
Publié: (2021)

Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations
par: Emilio Rintaro Suzuki Jr, et autres
Publié: (2010)

Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
par: Fan Li, et autres
Publié: (2021)

Corneal biomechanics in asymmetrical normal-tension glaucoma
par: Helmy H, et autres
Publié: (2016)

Optic Disc Hemorrhage and Lamina Cribrosa Defects in Glaucoma Progression
par: Hae-Young Lopilly Park, et autres
Publié: (2017)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
par: Miguel A Teus, et autres
Publié: (2009)

Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension
par: Syed MF, et autres
Publié: (2011)

Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
par: Makoto Aihara
Publié: (2010)

Corrigendum: Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations
par: Suzuki CLB, et autres
Publié: (2010)

Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension
par: Sophia K Mirza, et autres
Publié: (2010)

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
par: Lerner SF, et autres
Publié: (2019)

New nonlinear multivariable model shows the relationship between central corneal thickness and HRTII topographic parameters in glaucoma patients
par: Dimitrios Kourkoutas, et autres
Publié: (2009)

Corneal Hysteresis as a Biomarker of Glaucoma: Current Insights
par: Zimprich L, et autres
Publié: (2020)

Optic disc segmentation for glaucoma screening system using fundus images
par: Almazroa A, et autres
Publié: (2017)

Inter-Ocular Asymmetry in Anterior Corneal Aberrations Using Placido Disk-Based Topography
par: Alzaben Z, et autres
Publié: (2020)